Loading...

Waters Corporation

WATNYSE
Healthcare
Medical - Diagnostics & Research
$277.72
$-0.28(-0.10%)

Waters Corporation (WAT) Stock Overview

Explore Waters Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.0/100

Key Financials

Market Cap16.7B
P/E Ratio25.26
EPS (TTM)$11.09
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Week$347.69
1 Month$337.37
3 Months$346.86
1 Year Target$460.95

WAT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Waters Corporation (WAT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $460.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.26 and a market capitalization of 16.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;